BGLAF
BioGaia AG - Ordinary Shares - Class B

2
Loading...
Loading...
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
225

Frequently Asked Questions

What is Market Cap of BioGaia AG - Ordinary Shares - Class B?
What is the 52-week high for BioGaia AG - Ordinary Shares - Class B?
What is the 52-week low for BioGaia AG - Ordinary Shares - Class B?
What is BioGaia AG - Ordinary Shares - Class B stock price today?
What was BioGaia AG - Ordinary Shares - Class B stock price yesterday?
What is the PE ratio of BioGaia AG - Ordinary Shares - Class B?
What is the Price-to-Book ratio of BioGaia AG - Ordinary Shares - Class B?
What is the 50-day moving average of BioGaia AG - Ordinary Shares - Class B?
How many employess does BioGaia AG - Ordinary Shares - Class B has?

Latest BGLAF News

View
No BGLAF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.